Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

50
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
50
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

10.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.5K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Inflammatory Response01:28

Inflammatory Response

12.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.2K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

14.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term IFN-β Therapy Enhances and Prolongs IFN Responses in Multiple Sclerosis.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2026
Same author

Impaired inactive limb blood flow regulation in adults with multiple sclerosis during sympathoexcitatory stimuli.

Physiological reports·2025
Same author

IFN-β therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.

PloS one·2025
Same author

Two roads diverged in multiple sclerosis: When is switching therapy effective?

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Cardiovascular hemodynamic response to peak exercise in individuals with multiple sclerosis.

Physiological reports·2024
Same author

Alternative Splicing of RNA Is Excessive in Multiple Sclerosis and Not Linked to Gene Expression Levels: Dysregulation Is Corrected by IFN-β.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2024

Related Experiment Video

Updated: Apr 21, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.6K

Immunomodulatory activity of interferon-beta.

Lloyd H Kasper1, Anthony T Reder2

  • 1Departments of Microbiology/Immunology and Medicine, Geisel School of Medicine, Dartmouth College Hanover, New Hampshire.

Annals of Clinical and Translational Neurology
|October 31, 2014
PubMed
Summary

Multiple sclerosis (MS) is an immune-driven central nervous system disorder. Beta interferons (IFN-β) offer a therapeutic approach by modulating immune responses to reduce inflammation and disease progression.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

12.5K
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

9.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.6K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

12.5K
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

9.9K

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a central nervous system disorder characterized by inflammation, demyelination, and axonal loss.
  • Beta interferons (IFN-β) were the first approved disease-modifying therapies for MS, demonstrating efficacy in clinical trials.
  • The precise immunological mechanisms underlying IFN-β's therapeutic effects in MS require further elucidation.

Purpose of the Study:

  • To review the immunological mechanisms of action for beta interferons (IFN-β) in multiple sclerosis (MS).
  • To explore how IFN-β influences immune cells and cytokine networks to exert anti-inflammatory effects.
  • To highlight the pleiotropic actions of IFN-β contributing to its efficacy in managing MS.

Main Methods:

  • Literature review focusing on immunological mechanisms of Type I interferons in MS.
  • Analysis of studies investigating IFN-β's effects on immune cells (antigen-presenting cells, T cells, B cells).
  • Examination of research on IFN-β's impact on cytokine networks and inflammatory pathways.

Main Results:

  • Interferon-beta (IFN-β) modulates immune function at multiple levels, including antigen-presenting cells, T cells, and B cells.
  • IFN-β treatment shifts cytokine profiles towards an anti-inflammatory state.
  • These pleiotropic immunological effects are critical for IFN-β's efficacy in MS.

Conclusions:

  • Beta interferons (IFN-β) exert their therapeutic effects in multiple sclerosis (MS) through complex immunomodulation.
  • Understanding these immunological mechanisms is key to appreciating IFN-β's role in MS treatment.
  • Further research into Type I interferon actions can inform future therapeutic strategies for MS.